ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,721.60
0.00%
S&P ASX All Technology
3,063.30
0.00%
Brent Oil
83.935
0.45%
US Dollar vs AUD
1.51133
-0.61%
Bitcoin
62,594.86
2.30%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. XOMA Corporation (XOMA)

  7. XOMA Corporation (XOMA) News

XOMA

XOMA (XOMA)

XOMA Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XOMA
DateTimeSourceHeadlineSymbolCompany
09/05/202421:30GlobeNewswire Inc.XOMA Reports First Quarter 2024 Financial Results and Highlights Recent ActivitiesNASDAQ:XOMAXOMA Corporation
30/04/202421:30GlobeNewswire Inc.XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%NASDAQ:XOMAXOMA Corporation
25/04/202421:30GlobeNewswire Inc.XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)NASDAQ:XOMAXOMA Corporation
24/04/202423:00PR Newswire (US)Actym Therapeutics Appoints Thomas Smart as CEONASDAQ:XOMAXOMA Corporation
04/04/202400:00GlobeNewswire Inc.XOMA Corporation Announces Closing of Tender OfferNASDAQ:XOMAXOMA Corporation
21/03/202422:30GlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAXOMA Corporation
20/03/202407:05GlobeNewswire Inc.XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.NASDAQ:XOMAXOMA Corporation
08/03/202423:30GlobeNewswire Inc.XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder ValueNASDAQ:XOMAXOMA Corporation
28/02/202423:30GlobeNewswire Inc.XOMA to Present at Upcoming Investor Conferences in MarchNASDAQ:XOMAXOMA Corporation
17/02/202400:00GlobeNewswire Inc.XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value RightNASDAQ:XOMAXOMA Corporation
19/01/202400:30GlobeNewswire Inc.XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® AcquisitionNASDAQ:XOMAXOMA Corporation
12/01/202408:50Dow Jones NewsXoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for ArimoclomolNASDAQ:XOMAXOMA Corporation
12/01/202408:05GlobeNewswire Inc.FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRxNASDAQ:XOMAXOMA Corporation
08/01/202423:30GlobeNewswire Inc.XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of DirectorsNASDAQ:XOMAXOMA Corporation
02/01/202423:30GlobeNewswire Inc.XOMA Announces Stock Repurchase Program of up to $50 MillionNASDAQ:XOMAXOMA Corporation
20/12/202323:30GlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAXOMA Corporation
19/12/202323:30GlobeNewswire Inc.XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® RoyaltiesNASDAQ:XOMAXOMA Corporation
07/11/202323:30GlobeNewswire Inc.XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder ValueNASDAQ:XOMAXOMA Corporation
31/10/202322:30GlobeNewswire Inc.XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)NASDAQ:XOMAXOMA Corporation
25/09/202321:30GlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAXOMA Corporation
06/09/202321:30GlobeNewswire Inc.XOMA to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:XOMAXOMA Corporation
08/08/202321:30GlobeNewswire Inc.XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization StrategyNASDAQ:XOMAXOMA Corporation
24/06/202308:14GlobeNewswire Inc.XOMA Added to the Russell 2000® and Russell 3000® IndexesNASDAQ:XOMAXOMA Corporation
22/06/202321:30GlobeNewswire Inc.XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology AssetNASDAQ:XOMAXOMA Corporation
20/06/202321:30GlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAXOMA Corporation
26/05/202306:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XOMAXOMA Corporation
23/05/202306:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XOMAXOMA Corporation
23/05/202306:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XOMAXOMA Corporation
20/05/202307:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XOMAXOMA Corporation
20/05/202306:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XOMAXOMA Corporation
 Showing the most relevant articles for your search:NASDAQ:XOMA

Your Recent History

SPI
SP500
S&P 500
ASX
RIO
Rio Tinto
FX
AUDJPY
AUD vs Yen
ASX
SUN
Suncorp
ASX
QBE
QBE Insurance
ASX
NCM
Newcrest Mining
ASX
CBA
Commonwealth Bank Of Aus...
COIN
BTCUSD
Bitcoin
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
FX
EURAUD
Euro vs AUD
ASX
MQG
Macquarie
NASDAQ
AMZN
Amazon.com
ASX
AMP
AMP
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved